MicroRNAs and cancer


MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs.





 


    Related Conference of MicroRNAs and cancer

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    MicroRNAs and cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in